Delphinus Medical Technologies Inc. announced that it has secured a venture round of $39.5 million, the single largest amount ever raised for a healthcare imaging company in the Midwest. It is also the largest amount for a medical device company in Michigan.

Tiny gas microbubbles can enhance the delivery and absorption of cancer drugs in patients with advanced pancreatic cancer, according to a new pilot study. The study was described at the International Contrast Ultrasound Society (ICUS) annual conference in Chicago.

Women who have breast cancer on their left side present a particular challenge to radiation oncologists. Studies have shown that the risk of heart disease is higher in this group of women after radiation treatment. This is because it can be difficult to ensure a sufficient dose of radiation is delivered to the left breast while adequately shielding the heart from exposure. New research shows a woman who holds her breath during radiation pulses can greatly reduce radiation exposure to the heart.

The transition from film to flat panel has dramatically improved the efficiency of portable X-ray units. Transmitting images directly to viewing stations and PACS has streamlined operations by eliminating the need to return these systems to a home base for image processing. But this freedom has created inefficiencies of its own.

Digital radiography (DR) units can be just about anywhere. They may be functioning as they should — or not. And staff may or may not be nearby.

September 9, 2015 — The U.S. Food and Drug Administration (FDA) granted 510(k) for Philips Healthcare’s Spectral Diagnostic Suite (SpDS), which offers a set of advanced visualization and analysis tools designed for the IQon Spectral computed tomography (CT) technology. The software offers enhanced spectral viewing and clinical applications capabilities.

Ninety-six percent of clinics and hospitals in the United States that have purchased used or refurbished medical equipment have had neutral-to-positive experiences with the purchase, according to a new survey.

More than 50 women in need received free cervical and breast cancer screenings with same-day results as part of a recent See, Test & Treat program and health fair at Loyola University Medical Center.

SRI International and DataSpeaks Inc. announced that SRI has licensed the Science of Individuality Measurement Algorithm (SIMA) software from DataSpeaks. SRI will integrate SIMA into the development of a secure enterprise system for clinical decision-making.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now